APA

Caraglia M., Giuberti G., Marra M., Addeo R., Montella L., Murolo M., Sperlongano P., Vincenzi B., Naviglio S., Prete S. D., Abbruzzese A. & Stiuso P. (20111101). Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. : Cell death & disease.

Chicago

Caraglia M, Giuberti G, Marra M, Addeo R, Montella L, Murolo M, Sperlongano P, Vincenzi B, Naviglio S, Prete S Del, Abbruzzese A and Stiuso P. 20111101. Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. : Cell death & disease.

Harvard

Caraglia M., Giuberti G., Marra M., Addeo R., Montella L., Murolo M., Sperlongano P., Vincenzi B., Naviglio S., Prete S. D., Abbruzzese A. and Stiuso P. (20111101). Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. : Cell death & disease.

MLA

Caraglia M, Giuberti G, Marra M, Addeo R, Montella L, Murolo M, Sperlongano P, Vincenzi B, Naviglio S, Prete S Del, Abbruzzese A and Stiuso P. Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. : Cell death & disease. 20111101.